Search Results - "BUCHHOLZ, Erika"
-
1
European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer
Published in Clinical cancer research (01-01-2003)“…Purpose: The purpose of this study was to assess the activity and toxicity of a combined regimen of topotecan and cisplatin in “sensitive” (s) and “refractory”…”
Get full text
Journal Article Web Resource -
2
Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma
Published in Lung cancer (Amsterdam, Netherlands) (01-10-2006)“…Hypermethylation occurs frequently in neoplastic cells and affects tumorigenesis. Malignant mesothelioma is an aggressive cancer developing in the thoracic…”
Get full text
Journal Article -
3
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis
Published in Journal of thoracic oncology (01-01-2007)“…The combination of ifosfamide, carboplatin, and etoposide (ICE) is highly effective in treating small cell lung cancer (SCLC). Myelosuppression resulting in…”
Get more information
Journal Article -
4
Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Published in Cancer research (Chicago, Ill.) (15-03-2009)“…Cetuximab, which blocks ligand binding to epidermal growth factor receptor (EGFR), is currently being studied as a novel treatment for non-small cell lung…”
Get full text
Journal Article -
5
Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non-Small-Cell Lung Cancer
Published in Clinical lung cancer (01-05-2006)“…Gefitinib is an orally active epidermal growth factor receptor tyrosine kinase inhibitor with activity in previously treated patients with advanced-stage…”
Get full text
Journal Article -
6
A Pilot Trial of Gefitinib in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
Published in Clinical lung cancer (01-05-2005)“…Despite improvements in conventional treatment, patients with advanced non–small-cell lung cancer (NSCLC) have a poor prognosis, leaving a significant unmet…”
Get full text
Journal Article -
7
Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma
Published in Lung cancer (Amsterdam, Netherlands) (01-10-2006)“…Hypermethylation occurs frequently in neoplastic cells and affects tumorigenesis. Malignant mesothelioma is an aggressive cancer developing in the thoracic…”
Get full text
Journal Article -
8
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
Published in Lung cancer (Amsterdam, Netherlands) (01-06-2005)“…In the treatment of extensive disease of small cell lung cancer (ED SCLC) there is an urgent need for more effective and better-tolerated drug regimens. We…”
Get full text
Journal Article -
9
-
10
P-558 Phase-II trial of topotecan and etoposide in extensive disease small cell lung cancer (ED-SCLC)
Published in Lung cancer (Amsterdam, Netherlands) (01-08-2003)Get full text
Journal Article